Browsing by Author "Poole, Danielle."
Now showing 1 - 1 of 1
- Results Per Page
- Sort Options
Item Preservation HIV-1–specific IFNg+ CD4+ T-Cell responses in breakthrough infections after exposure to tenofovir gel in the CAPRISA 004 microbicide trial.(Lippincott Williams & Wilkins., 2011) Mureithi, Marianne W.; Poole, Danielle.; Naranbhai, Vivek.; Reddy, Shabashini.; Mkhwanazi, Nompumelelo Prudence.; Sibeko, Sengeziwe.; Werner, Lise.; Abdool Karim, Quarraisha.; Abdool Karim, Salim Safurdeen.; Ndung'u, Peter Thumbi.; Altfeld, Marcus.Abstract: The Centre for the AIDS Program of Research in South Africa 004 trial demonstrated reduction of sexual HIV-1 acquisition in women using a vaginal microbicide containing tenofovir. A better understanding of the consequences of antiretroviral-containing microbicides for immune responses in individuals with intercurrent HIV-1 infection is needed for future trials combining the use of microbicides with HIV-1 vaccines. Investigation of immune responses in women who acquired HIV-1 although using tenofovir gel showed significantly higher (P = 0.01) Gag-specific IFNγ+ CD4+ T-cell responses. The use of tenofovir-containing gel around the time of infection can modulate HIV-1 immunity, and these immunological changes need to be considered in future trials combining vaccines and microbicides.